Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF vs G-CSF+GM-CSF for Stem Cell Mobilization in Normal Donors
NCT00208949Phase 2Terminated
- Sponsor
- Emory University
- Start
- Sep 2002
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in hematologic diseases, sponsored by Emory University. Started Sep 2002; status: terminated.
02
Drugs
sargramostim
03
Conditions
hematologic diseases
Beyond the preview
Go deeper on NCT00208949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208949.